Multiple solutions of etoposide and topotecan are on back order.

First-time pass rates for the North American Pharmacist Licensure Examination have slightly dipped in the past two years, according to data from the National Association of Boards of Pharmacy. 

Feb.1 marks the first day that federal officials will negotiate the price for 10 of the most expensive drugs as part of the Biden administration's Inflation Reduction Act, The Hill reported.

Among the rise in popularity of weight-loss drugs, an "obesity bill of rights" has been published and endorsed by nearly 40 national obesity, and chronic disease organizations, with the aim to have providers incorporate the standards into medical practice.

On Feb. 1, the American Society of Health-System Pharmacists appointed five leaders to its new digital and telehealth practitioners committee. 

The average all-time pass rate of the North American Pharmacist Licensure Examination was 75.7% in 2023 — a slight increase from the year prior, according to data from the National Association of Boards of Pharmacy. 

The spike in syphilis cases across the U.S. are spurring public health agencies to recommend that clinicians ration penicillin injectables, the preferred treatment, KFF Health News reported Feb. 1. 

As part of its new cell and gene therapy access tool, HHS' first focus is improving access to sickle cell disease therapies, which can cost millions of dollars for a one-time dose. 

Biogen is discontinuing its Alzheimer's drug Aduhelm, which was approved in 2021 but became snarled in efficacy concerns and payers' refusals to cover the medication. 

After laying off 5% of its corporate workforce in November, Walgreens will lay off 145 more workers, most of whom are corporate employees, the company confirmed to Becker's.